Fierce Pharma
JULY 10, 2024
It’s well known that obesity drugs from Novo Nordisk and Eli Lilly are on a high-flying growth trajectory that doesn’t look to be letting up anytime soon. | Novo Nordisk's Ozempic is slated to take over No.1, while Merck's Keytruda falls to No.9 on Evaluate's predicted rankings of top drugs by 2030 sales.
MedCity News
JULY 10, 2024
CMS issued its proposed rule for next year’s Medicare physician fee schedule, revealing plans to cut payment rates by 2.8%. Industry groups swiftly expressed their outrage, arguing that reimbursement rates need to keep up with the pace of inflation. The post Why Industry Groups Are Decrying CMS’ Physician Fee Schedule Proposal appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JULY 10, 2024
While much of the attention on Novo Nordisk these days revolves around the company’s wildly popular GLP-1 drugs Ozempic and Wegovy, insulin remains a critical backbone for the drugmaker. | As Novo Nordisk steadily ups its commitments in Asia, the company is teaming up with Indonesia’s state-owned pharmaceutical firm Bio Farma to bolster insulin packaging in the southeast Asian nation.
Pharmaceutical Commerce
JULY 10, 2024
In an interview with Pharma Commerce editor Nicholas Saraceno, Peter Ax, UpScriptHealth, founder and CEO, offers his thoughts surrounding the lack of supply.
Fierce Pharma
JULY 10, 2024
Editor's note: This story was corrected to note that Brooks will be Eli Lilly's interim CFO. | Gordon Brooks, currently Eli Lilly's group vice president, controller and corporate strategy, will take the interim role after 29 years at the drugmaker.
ALULA
JULY 10, 2024
Earlier this year, I had the pleasure of giving an invited talk at the Organizational Behavior Management ( OBM ) Network Conference in Houston, TX. I knew it would be a great opportunity to engage with OBM professionals and researchers on a challenge that everyone shares right now: facing the inevitability of change, particularly career change.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JULY 10, 2024
Hospitals would be much better served by focusing on reuse and reprocessing programs. So why isn’t that happening and what can be done about it? The post Medical Device Recycling Programs Are Manufacturer Money-Grabs Disguised as Sustainability Initiatives appeared first on MedCity News.
Fierce Pharma
JULY 10, 2024
Pharmaceutical CEOs often earn pay packages worth tens of millions of dollars for leading the top drugmaking companies in the industry. | In this week's episode of "The Top Line," Fierce Pharma’s Eric Sagonowsky and Fraiser Kansteiner discuss Fierce’s annual special report, “Big Pharma's 10 highest-paid CEOs.
MedCity News
JULY 10, 2024
Is it possible to be pro-human and pro-tech at the same time when it comes to our healthcare? The post “Robotic-based” Home Care is Actually More … Human appeared first on MedCity News.
PharmaVoice
JULY 10, 2024
The company has begun searching for a successor to Dolsten, who oversaw more than 35 drug and vaccine approvals alongside notable setbacks during his time as Pfizer’s top scientist.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MaBiCo
JULY 10, 2024
Medical Sales Rep Recruitment (Part 2): How to optimize the hiring process to select top talent. In our previous article, we explored the fundamental steps necessary for implementing an effective medical representative selection process. These steps included identifying key characteristics exhibited by top-performing salespeople and using them as benchmarks for hiring.
MedCity News
JULY 10, 2024
Unlike GLP-1 agonist drugs marketed for weight loss, new Amylyx Pharmaceuticals drug avexitide blocks its target receptor. Amylyx plans to advance this GLP-1 antagonist into Phase 3 testing for post-bariatric hypoglycemia, a rare condition in which blood sugar levels drop precipitously. The post Amylyx Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think appeared first on MedCity News.
pharmaphorum
JULY 10, 2024
After short but worrying delay, Arcutis gets FDA approval for flagship drug Zoryve in atopic dermatitis, which could further unlock sales growth
Pharmaceutical Technology
JULY 10, 2024
Almirall’s Ebglyss is predicted to hit blockbuster status in two years in the crowded atopic dermatitis market.
PharmaTimes
JULY 10, 2024
Around one in five dementia hospitalisations are due to potentially preventable causes
pharmaphorum
JULY 10, 2024
Shares in Dutch biotech uniQure shoot up after Huntington’s candidate AMT-130 slows disease progression by 80% two years after dosing.
Pharmaceutical Technology
JULY 10, 2024
Evotec and Pfizer have entered a multi-year partnership that will focus initially on early discovery research.
Pharmaceutical Commerce
JULY 10, 2024
Why these programs require a hybrid approach that combines technology and human connection.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Clarivate
JULY 10, 2024
Summary: Older research often presents fresh opportunities to advance scientific and scholarly research today. Learn more about a few notable examples. Staying up to date with the newest findings in a field is critical in today’s fast-paced research environment. Researchers need to ensure that they are pursuing novel ideas and incorporating the most recent evidence in their work.
MedCity News
JULY 10, 2024
A new partnership will give Hello Alpha patients access to Phenomix Sciences’ genetic obesity test. The post Hello Alpha, Phenomix Sciences Launch Partnership for Genetic Obesity Test appeared first on MedCity News.
PharmaTimes
JULY 10, 2024
The neurodegenerative condition currently affects more than 944,000 people in the UK
Clarivate
JULY 10, 2024
Securing patent protection across diverse jurisdictions demands efficient coordination with local agents. However, outdated communication methods hinder this process. Learn how IP Collaboration Hub from Clarivate streamlines communication for a modern approach to managing a global network of agents. In today’s global marketplace, securing patent protection in jurisdictions around the world is a crucial step on the path from innovation to commercialization.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Commerce
JULY 10, 2024
The latest news for pharma industry insiders.
Pharmatutor
JULY 10, 2024
Serum : Effective mode with high concentration of actives Pradip Mahajan Thu, 07/11/2024 - 11:47 Vinay Kumar Singh. Head-Formulation Kumar Organic Products Research Centre Pvt. Ltd., Bengaluru Email : formulation_krc@kopresearchcentre.
Evolve Your Success
JULY 10, 2024
Unlock the secrets to transforming your career in medical sales as we sit down with Kendy Elmore, the visionary founder of The Lobby. Learn how Kendy went from being a seasoned medical sales rep to creating a game-changing platform that connects and empowers professionals in the industry. Discover how The Lobby’s live events, now spanning 22 cities, including one in Canada, have become indispensable for networking, professional growth, and community building within the medical sales world.
PharmaTech
JULY 10, 2024
The acquisition of uniQure’s Lexington, Mass., manufacturing operations will boost Genezen’s late-phase and commercial gene therapy development and manufacturing services.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Pharmaceutical Technology
JULY 10, 2024
IntegriChain, a provider of data-driven commercialisation solutions for the pharma industry, has acquired Federal Compliance Solutions (FCS).
PharmExec
JULY 10, 2024
Zoryve is a steroid-free, once-daily treatment shown to offer rapid disease clearance and significant itch reduction for patients with mild to moderate atopic dermatitis.
Pharmaceutical Technology
JULY 10, 2024
Lomecel-B is also being investigated for treating hypoplastic left heart syndrome, and ageing-related frailty, in addition to Alzheimer’s.
pharmaphorum
JULY 10, 2024
NICE backs monthly eczema drug from Almirall Phil.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Expert insights. Personalized for you.
266 
Let's personalize your content